Pages

Showing posts with label Pharmaceutical Industry. Show all posts
Showing posts with label Pharmaceutical Industry. Show all posts

Lawyers: U.S. faces suit on syphilis tests in Guatemala

CNN News, By Ed Payne and Cristy Lenz, March 9, 2011

STORY HIGHLIGHTS
  • Lawyers say about 700 Guatemalans were infected with syphilis
  • The U.S. intentionally infected the Guatemalans to study the effects of the disease
  • The United States has apologized for the testing, which was more than 60 years ago

(CNN) -- The U.S. government will be hit with a class action lawsuit on behalf of 700 Guatemalans who were infected with syphilis unless it offers a way to settle claims before Friday, the plaintiffs' attorneys said.

Guatemalan President Alvaro Colom has described
the syphilis experiments as crimes against humanity.
Law firms representing the victims said the United States intentionally infected the Guatemalans between 1946 and 1948 in an effort to study the effects of the disease.

The complaint compares it to the Tuskegee syphilis experiment in Alabama. During the 40-year study that began in 1932, doctors observed how the disease progressed in about 400 poor African-Americans, who already had syphilis. The men were never told they had the disease and never treated for it. The test subjects received free medical testing, meals and burial insurance.

"We are hoping we can come up with a mutual agreement by Friday about what next steps should be in terms of a concrete remedy for the people that were impacted," Piper Hendricks, a litigation associate for Conrad and Scherer, said Tuesday.

"We were favorably impressed with how the administration denounced the studies and apologized last year; we hope we can come up with a settlement without actually having to go to court and litigate."

The Obama administration acknowledged the experiments in October.

RELATED TOPICS

"Although these events occurred more than 64 years ago, we are outraged that such reprehensible research could have occurred under the guise of public health," Secretary of State Hillary Clinton and Health and Human Services Secretary Kathleen Sebelius said in a joint statement. "We deeply regret that it happened, and we apologize to all the individuals who were affected by such abhorrent research practices."

While the complaint mentions that there were at least 700 test subjects, it only lists seven plaintiffs -- all are either the direct victims of the testing or their legal heirs.

"We do expect more people to come forward, but the news is still making its way through Guatemala," said Hendricks, who acknowledged that many people may have passed away over the years. "Some of our clients are living in rural regions and even if they have received news of what went on it's not easy to get in touch with someone to join the suit."

In a letter to Attorney General Eric Holder on Monday, attorneys Andres Alonso and Terrence Collingsworth ask that "a claims process be set up through which aggrieved citizens of Guatemala, who have been adversely affected by this experiment," can receive a settlement outside the court system.

The legal team says it will proceed with the litigation if it doesn't hear from the government by Friday.

Related Articles:




Read more

Japan halts vaccines after deaths of 4 children

The Jakarta Post, Associated Press, Tokyo | Mon, 03/07/2011 

Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were inoculated, the health ministry said Monday.

The decision to halt the vaccines against pneumonia, some types of meningitis and other infections was made Saturday. The government is hearing from experts at a meeting Tuesday, the health ministry said.

The four children, from under six months to 2 years old, died between March 2 and March 4. The deaths occurred the same day to three days after the vaccines were administered, the ministry said.

The vaccination began in Japan about a year to two years ago. The vaccines have been administered to 1 million to 1.5 million children, according to the ministry.

Pfizer in Japan said the company was cooperating with the investigation on the Prevenar vaccine. The U.S. has been using Prevenar for about 10 years, the company said.

Sanofi-Aventis in Japan said its ActHIB vaccine was approved in France in 1992, and a year later in the U.S.

Read more

Doggy Prozac & Female Viagra: Big Pharma's new 'syndrome' strategy

US pharmaceutical companies get creative when it comes to disorders and drugs to treat almost anything, from canine depression to female sexual dysfunction. The American drug trade is a multi-billion-dollar business, and is only getting bigger. Meanwhile the industry has been accused of illegally pushing medicine onto the market, often endangering the lives of patients. In the US, the most common medication prescribed for dogs is to treat aggression and anxiety disorders. Pharmacists admit that Prozac works





Related Articles:

Read more

Negative experiences can stop painkillers working

BBC News, By James Gallagher ,Health reporter, 16 February 2011

Related Stories

A patient's belief that a drug will not work can become a self fulfilling prophecy, according to researchers.

Negative thoughts rendered painkillers ineffective
They showed the benefits of painkillers could be boosted or completely wiped out by manipulating expectations.

The study, published in Science Translational Medicine, also identifies the regions of the brain which are affected.

Experts said this could have important consequences for patient care and for testing new drugs.

Heat was applied to the legs of 22 patients, who were asked to report the level of pain on a scale of one to 100. They were also attached to an intravenous drip so drugs could be administered secretly.

The initial average pain rating was 66. Patients were then given a potent painkiller, remifentanil, without their knowledge and the pain score went down to 55.

They were then told they were being given a painkiller and the score went down to 39.

Then, without changing the dose, the patients were then told the painkiller had been withdrawn and to expect pain, and the score went up to 64.

So even though the patients were being given remifentanil, they were reporting the same level of pain as when they were getting no drugs at all.

Professor Irene Tracey, from Oxford University, told the BBC: "It's phenomenal, it's really cool. It's one of the best analgesics we have and the brain's influence can either vastly increase its effect, or completely remove it."

The study was conducted on healthy people who were subjected to pain for a short period of time. She said people with chronic conditions who had unsuccessfully tried many drugs for many years would have built up a much greater negative experience, which could impact on their future healthcare.

Professor Tracey said: "Doctors need more time for consultation and to investigate the cognitive side of illness, the focus is on physiology not the mind, which can be a real roadblock to treatment."

Brain scans during the experiment also showed which regions of the brain were affected.

The expectation of positive treatment was associated with activity in the cingulo-frontal and subcortical brain areas while the negative expectation led to increased activity in the hippocampus and the medial frontal cortex.

Researchers also say the study raises concerns about clinical trials used to determine the effectiveness of drugs.

George Lewith, professor of health research at the University of Southampton, said: "It's another piece of evidence that we get what we expect in life.

"It completely blows cold randomised clinical trials, which don't take into account expectation."

Read more

US pharm industry creates diseases to cure them

RT, 14 February, 2011

US pharmaceutical companies get creative when it comes to disorders and drugs to treat almost anything, from canine depression to female sexual dysfunction.

The American drug trade is a multi-billion-dollar business, and is only getting bigger. Meanwhile the industry has been accused of illegally pushing medicine onto the market, often endangering the lives of patients.

In the US, the most common medication prescribed for dogs is to treat aggression and anxiety disorders. Pharmacists admit that Prozac works terrifically on dogs.

Yes, there is such a thing as doggy Prozac, a beef-flavored version of the well-known “human” anti-depressant, government-approved and being proscribed by veterinarians for canines in crisis.

“There is a significant population of dogs which is really suffering from separation anxiety,” reveals veterinary behaviorist E'Lise Christensen, from NYC Vet Specialists.

The drug company, one of the largest, is banking on that. They believe up to 17 per cent of US dogs are suffering from this mental affliction. It is an idea some would scoff at, and as Christensen says “I definitely understand being skeptical.”

“Companies are desperate to keep up their profit margin, and do things to keep the margin up, even though the number of new drugs that are important in the pipeline has diminished,” argues Dr. Sidney Wolfe, director of Public Citizen’s Health Research.

It turns out those companies do not need doggy drugs in order for critics to make that case. Medical researchers have crunched the numbers and found the pharmaceutical industry now tops the defense industry as the number one defrauder of the US government.

“That was a finding that I didn't expect. No one had really ever looked at it before and it shows you how out-of-control really the pharmaceutical industry really is,” Dr. Sidney Wolfe said.

In some cases it is criminally out of control, perhaps helping this industry go from selling US$40 billion to $234 billion a year in prescription drugs. Over the last two decades, companies have been cheating and endangering patients. Their biggest violations are overcharging the government by billions and illegally marketing their drugs to treat conditions for which they have not proven safe or effective.

One of the largest criminal penalties ever levied against an American corporation involved the drugs giant Pfizer. The illegal practices included essentially hiring positions despite the buzz about the drug, telling their colleagues to prescribe it for a condition it was not approved for.

And when it comes to the drug companies, disease-pushers may not be an unfair way of describing them, as well as drug pushers – that is what one filmmaker found when tracing a newly-minted disorder.

“Female sexual dysfunction itself is something the pharm industry really pushed for and had a hand in creating,” believes Liz Canner, filmmaker of Orgasm Inc.

That is the conclusion Canner came to after following the process of a drug company developing female Viagra. She says only a small number of women need it, but the company has other plans.

“Their marketing and the amount of money they’re pouring into it really says they’re trying to sell this to the whole population,” insists Liz Canner.

And with commercials for prescription drugs airing on TV in the US, companies are in a position to do just that.

With billions being made and not much to lose, critics say even in the case of crime, for this industry nothing is likely to change.

“Unless people go to jail unless the fines are much larger than they have been the companies will find that it's cheaper to cheat” Dr. Sidney Wolfe said.

Companies that stop short of nothing to find some-syndrome, someone or something new to medicate.


Related Article:

Read more

Drug companies pay 17,000 U.S. doctors, report finds

Reuters, WASHINGTON | Tue Oct 19, 2010 2:09pm EDT
(Reuters) - More than 17,000 doctors and other healthcare providers have taken money from seven major drug companies to talk to other doctors about their products, a joint investigation by news organizations and non-profit groups found.

More than 380 of the doctors, nurses, pharmacists and other professionals took in more than $100,000 in 2009 and 2010, according to the investigation released on Tuesday. The report said far more doctors are likely to have taken such payments, but it documented these based on information from seven drugmakers.

The payments are not illegal and usually not even considered improper. But the investigation by journalism group ProPublica, Consumer Reports magazine, NPR radio and several publications showed doctors were sometimes urged to recommend "off-label" prescriptions of drugs, meaning using them for conditions they are not approved for.

And the report points to several studies showing that even small gifts and payments to doctors can affect their attitudes, and many companies have stopped giving out once-common gifts such as pens, cups and other objects carrying drug brand names.

"Tens of thousands of U.S. physicians are paid to spread the word about pharma's favored pills and to advise the companies about research and marketing," the group says in its report, available here

The groups used information from seven drugmakers -- AstraZeneca, Cephalon, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Merck and Pfizer.

"Some of the companies were forced to disclose this information as a result of legal settlements; others released it voluntarily," Consumer Reports said.

It said more than 70 other pharmaceutical companies have not disclosed payments made to doctors, although the healthcare reform law passed in March will require them to do so by 2013.

"This investigation begins to pull back the shroud on these activities," Dr. John Santa, director of the Consumer Reports Health Ratings Center, said in a statement.

"The amount of money involved is astounding, and the ProPublica report's account of the background of some of the physicians is disturbing."

Drug companies often say they pay expert physicians to educate their peers about drugs and conditions. These sessions are often seminars held alongside major medical meetings but sometimes they involve briefings at vacation resorts.

ProPublica said a review of state medical board disciplinary records found more than 250 of the doctors paid to speak had been sanctioned for activities such as inappropriately prescribing drugs or having sex with patients.

It said 40 others had been warned by the U.S. Food and Drug Administration for research misconduct, had lost hospital privileges or were convicted of crimes.

(Reporting by Maggie Fox; Editing by Julie Steenhuysen and Eric Beech)

Read more

Experts admit swine flu jab 'may cause' deadly nerve disease

Daily Mail, By JO MACFARLANE, 16th October 2010

Health chiefs have for the first time acknowledged that the swine flu jab may be linked to an increased risk of developing a deadly nerve condition.

Experts are examining a pos sible association between the controversial jab and Guillain-Barre Syndrome, according to a report from official watchdog the Medicines and Healthcare products Regulatory Agency (MHRA).

Previously, the Government has always stressed there is no evidence to link the paralysing condition to the H1N1 vaccine.

Fears: GBS victim Hilary Wilkinson wants
more research on the vaccine
After The Mail on Sunday revealed in August 2009 that doctors were being asked to monitor cases of GBS during the swine flu pandemic, a letter from the Health Protection Agency’s chief executive Justin McCracken stated: ‘There is no evidence to suggest an increased risk of GBS from the vaccines being developed to fight the current pandemic.’

Now the MHRA’s newly published report suggests the Government’s position has changed.

It says: ‘Given the uncer tainties in the available information and as with seasonal flu vaccines, a slightly elevated risk of GBS following H1N1 vaccines cannot be ruled out. Epidemiological studies are ongoing to further assess this possible association.’

It is not known precisely what causes GBS but the condition attacks the lining of the nerves, leaving them unable to transmit signals to muscles effectively.

It can cause partial paralysis and mostly affects the hands and feet – but it can be fatal.

The MoS report last year
Mother-of-two Hilary Wilkinson, 58, from Maryport, Cumbria, developed GBS following a chest infection and spent three months in hospital learning to walk and talk again.

She said: ‘It’s a frightening illness and I think more research needs to be done on the effect of the swine flu vaccine.’

A vaccine used to combat a different form of swine flu in the US in 1976 led to 25 deaths from the condition, compared with just one death from swine flu itself.

Amid fears there could be a repeat, neurologists were asked to record cases of GBS in the UK swine flu outbreak. Millions of people this year will be exposed to the swine flu vaccine as it has been included within the seasonal flu jab.

Government experts say there is no evidence of an increase in risk similar to 1976, but the MHRA report reveals they are calculating if there might be a smaller raised risk.

The MHRA had 15 suspected GBS cases after vaccination – and six million doses of the swine flu jab Pandemrix were given. It is not known if swine flu or the vaccine could have caused the suspected cases.

A spokeswoman for the MHRA said the risk with the vaccine had not changed and that the report ‘simply expands’ on ongoing GBS analysis.

Read more

Who’s to blame for our antibiotics addiction?

Triwik Kurniasari, The Jakarta Post, Jakarta | Sun, 08/29/2010 11:19 AM

The widespread use of antibiotics has become a major global public health sector problem. The UN World Health Organization (WHO) has urged countries to reinforce national policies on the prudent use of antibiotics to reduce the alarming increase in poorly monitored consumption.

A traveler walks past a drug store at Gambir train
station in Central Jakarta. Different brand of antibiotics
 are easily available as over-the-counter medicine,
 which contributes to the excessive use of the drugs.
JP/Ricky Yudhistira
How have antibiotics become a new source of addiction?

As health experts are busy debating the impact of excessive use of antibiotics, the WHO has called on governments, medical practitioners and the pharmaceutical industry to guard against possible problems associated with antibiotics, especially the potential for microbial resistance.

But what exactly is an antibiotic?

An antibiotic is essentially a substance used for curing illnesses by killing or injuring microbes, including bacteria, pharmacologist Nicolaski Lumbuun of the Pelita Harapan University Medical School said.

Antibiotics have widely been used since the 19th century following research on bacteria by Louis Pasteur and Robert Koch, who discovered that some microorganisms were capable of destroying other microorganisms.  The experiment led to Alexander Fleming’s discovery of penicillin in 1928, which was developed further by English and German scientists.

The invention resulted in a medical revolution, first by significantly reducing mortality rate, Nicolaski said.

“Antibiotics are safe for most human beings, but it have side effects causing allergies, rashes, itching, swelling and even Stevens-Johnson syndrome, which can lead to death,” Nicolaski told The Jakarta Post recently. 

Stevens-Johnson syndrome is a life-threatening condition affecting the skin.

Antibiotics should only be used to treat bacterial infections with symptoms such as fever or inflammation lasting longer than five days, Nicolaski said.

“Antibiotics fight bacteria-related illness, so they are not suitable for treating influenza or the common cold, which are caused by viruses,” he added.

In Indonesia, people tend to excessively consume antibiotics because they are over-the-counter medicines that can be found in drugstores, or even in roadside stalls. In many cases, physicians easily prescribe antibiotics in hopes that their patients swiftly recover. 

Nicolaski once again warned about the side effects of antibiotics.

“First, it is a waste of money because antibiotics are usually expensive. They can lead to allergic reactions and digestion problems. But the most serious effect is that excessive use of antibiotics can
raise the resistance to dangerous bacteria. This situation makes it difficult for doctors to control
infections.” 

Some bacteria become immune if an antibiotic is used over a long period of time, Nicolaski said, adding that this is why some countries have imposed strict regulations over the use of antibiotics.

“In Singapore, for instance, drug stores can only give antibiotics to customers with a prescription from licensed physicians. Such regulations protect citizens,” Nicolaski said.

Other experts have warned about the issue of antibiotics resistance because of microorganisms’ ability to mutate and develop immunity, the chairman of Eijkman Institute for Molecular Biology Malaria Laboratory, Syafruddin, said.

Research indicated that some organisms, such as Staphylococcus aureus, had built up immunity against meticillin, a penicillin-class antibiotic used to treat infection, he said.

Syafruddin also blasted doctors who over-prescribed antibiotics despite knowledge of the associated risks, and suggested that doctors asked their patients about allergies to antibiotics.

“If doctors are not sure about their diagnoses, they shouldn’t give their patients antibiotics,” he said.
Syafruddin added that doctors should be encouraged to provide patients with more general medicines to prevent antibiotic resistance. 

While many doctors freely offer their patients antibiotics, there are other doctors who are more cautious.

Nina, a doctor who refused to give her full name, said that she only prescribed antibiotics if her patient suffered from a high fever for more than three days.

“I will prescribe regular [non-antibiotic] medication if my patient’s fever lasts less than three days. If the fever lasts longer than three days, I will prescribe an antibiotic. But I check the patient’s condition before I make the prescription,” she said.

It is also important to ask patients whether they have allergies when they request prescriptions for antibiotics, Nina said.

“Sometimes parents panic when their children are sick and ask the doctor to prescribe antibiotics. Many people think that antibiotics will solve illnesses immediately.

I myself will not prescribe antibiotics if the patients don’t need it, and I will give the reason why,” Nina said, adding that pregnant women have to be careful because the consumption of antibiotics can give harm the fetus.

But some people are simply clueless about antibiotics and the possible effects they may have. 

“I don’t even know what an antibiotic is. All I know is that if the doctor gives us an antibiotic, we must eat it, but I never ask my doctor why,” said Gayatri Nur Andewi, a 28-year-old mother of two.

“I don’t want my kids taking too much of any medicine, and I stop giving them the drugs once they feel better.

The most important thing is that the sickness is gone,” Gayatri said. She said she never bought antibiotics without a prescription because it was too risky.

“It’s a matter of safety. I don’t know what antibiotics are available in stores,” she said.

For others, antibiotics are their drugs of choice. Private employee Gracia Maya Savitri said she bought antibiotics from drugstores without a prescription.

“Yes, I bought Amoxicillin for my toothache. My dentist suggested I take the antibiotic and I buy them without a prescription,” she said.

“I used to give my sick toddlers antibiotic syrup, but I only gave it for three days,” she said.

Why does not she consult a physician? “I don’t want to stand in line, especially as my pediatrician
has a lot of patients,” Gracia said. 

Nicolaski urged the public not to buy antibiotics without a prescription.

“If you get a cough, cold or flu [for less than three days], it’s not recommended to take antibiotics without a doctor’s prescription, because these illnesses are caused by viruses and antibiotics won’t work,” Nicolaski said. The excessive use of antibiotics to fight ailments like common colds has contributed to a global antibiotic resistance crisis, he said.

“Don’t use antibiotics for prevention, such as taking antibiotics before or after having sexual intercourse with a sex worker. The medicine will not prevent sexually transmitted infections,” he said.

Nicolaski also encouraged patients to prevent infection and side effects by maintaining discipline when a doctor prescribed an antibiotic.

The WHO also recommended that governments ensure rational use of antibiotics by educating healthcare workers and the public on the most appropriate dosage.

Read more

National scene: Herbal medicine market expanding, researcher says

The Jakarta Post | Thu, 08/19/2010 8:25 AM | National

YOGYAKARTA: The herbal medicine market has been expanding every year with Rp 6 trillion estimated for this year’s domestic sales, a researcher from Gadjah Mada University’s Pharmacology Department said.

“The domestic market of herbal products grew from Rp 1 trillion [US$111 million] in 2000 to Rp 2 trillion in 2002. It has grown steadily and this year the market is estimated to see Rp 6 trillion,” Mae Sri Hartati Wahyuningsih said Wednesday.

She said chemical drugs could not replace herbal medicines so the consumption of herbal medicine increased every year. “Indonesians have known the benefits of various plants for health treatment ingredients, curative substances or beauty,” she said as quoted by Antara.

She said many businesspeople saw it as opportunity for investment. Many herbal medicine producers are home industries but several have produced herbal ingredients on a large scale distributing them nationwide even outside the country.

“Using herbal medicines is common practice for Indonesians and many have experienced benefits,” she said. “There are an estimated 30,000 species of plants in Indonesia and about 9,600 could be used for medicine. From that number, only 300 are used as ingredients.” — JP

Read more

Swine flu advisers' ties to drug firms: Five WHO experts linked with vaccine producers

Daily Mail, By SOPHIE BORLAND, 13th August 2010

A third of the experts advising the World Health Organisation about the swine flu pandemic had ties to drugs firms, it has emerged.

Five of the 15 specialists who sat on the emergency committee had received funding from pharmaceutical giants, or were linked to them through their research.

The revelation will prompt speculation that the 'pandemic' was wildly overestimated and largely fuelled by the drugs industry who stood to benefit from the panic.


Last month it emerged that the Government had spent more than £1.2 billion tackling swine flu - most of it going towards vaccines

Last month it emerged that the Government had squandered more than £1.2 billion tackling swine flu - most of it going towards vaccines following experts' dire predictions that as many as 65,000 Britons would die.

In fact the virus claimed just 457 lives - a third of those killed every year by ordinary seasonal flu.

But today it emerged that many of the scientists on the WHO's emergency panel had links with firms including GlaxoSmithKline, who made millions manufacturing swine flu vaccines.

It follows revelations by the Daily Mail earlier this year that more than half of the scientists advising the British Government's own taskforce on the pandemic had links to drugs giants.

One of the 15 scientists advising the WHO was British professor Neil Ferguson - who last year warned the pandemic would be so bad all schools would need to close.

It has since emerged that Professor Ferguson had acted as a consultant for Roche, who makes Tamiflu, as well as GSK Biologicals until 2007.

Professor Maria Zambon, who was also on the panel, from UK Health Protection Agency's Centre for Infection, said she received funding from several vaccine makers, including Sanofi, Novartis, CSL, Baxter and GSK.

During the outbreak last year Professor Zambon warned that up to a third of school children in Britain had the virus without knowing as they did not have symptoms.

Meanwhile US professor Arnold Monto admitted he had done research for GlaxoSmithKline, Baxter, the two firms contracted to make the jabs, as well as Roche, which makes Tamiflu.

He had also done work for two other large firms Novartis and Sanofi Pasteur.

Critics warned that there was serious conflict of interest amongst these experts whose advice had led to the waste of vast sums of taxpayer's money.

Labour MP Paul Flynn said: 'A year ago, these experts told us the world was facing a grave health emergency.

'On this occasion, regrettably, they got it wrong: their advice led WHO, the EU and national governments to vastly overrate the seriousness of the H1N1 epidemic, wasting large sums of public money and scaring the world unnecessarily.

'With such conflicting pressures, we need to be absolutely certain that the advice of such experts is based on solid scientific evidence and is driven solely by the need to protect public health. The only way to do that is through total transparency.

'When a future pandemic is declared, the public has a right to know, from the outset, who is recommending such a drastic step – as well as any links they may have to the pharmaceutical industry, which stands to profit from such a recommendation.'

Another expert Nancy Cox, from the US Centers for Disease Control, admitted she had received funding from the drugs industry group, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) for flu vaccine research and work on viruses.

British scientist John Wood admitted that his research unit at Britain's National Institute for Biological Standards and Control (NIBSC), had undertaken work for Sanofi Pasteur, CSL, IFPMA, Novartis and Powdermed on influenza vaccine.

The panel were instrumental in advising the WHO to officially declare swine flu as the first pandemic in 40 years last June.

Earlier this year it emerged that 11 of the 20 members of the Scientific Advisory Group for Emergencies, which advised the British Government on swine flu, had done work for the pharmaceutical industry or were linked to it through their universities.

A spokesman for the WHO denied that the experts' work gave rise to a conflict of interest.


Related Articles:

Read more

Insulin giant pulls medicine from Greece over price cut

BBC News, by Malcolm Brabant, Saturday, 29 May 2010 10:53 UK

BBC News, Athens The Danish company's decision has been criticised in Greece

The world's leading supplier of the anti-diabetes drug insulin is withdrawing its medication from Greece.

Novo Nordisk, a Danish company, objects to a government decree ordering a 25% price cut in all medicines.

People with diabetes in Greece have condemned the Danish action as "brutal capitalist blackmail".

More than 50,000 Greeks with diabetes use Novo Nordisk's state of-the-art-insulin, which is injected via an easy-to-use fountain pen-like device.

A spokesman for the Danish pharmaceutical company said it was withdrawing the product from the Greek market because the price cut would force its business in Greece to run at a loss.

The company was also concerned that the compulsory 25% reduction would have a knock-on effect because other countries use Greece as a key reference point for setting drug prices.

'Insensitive'

Greece wants to slash its enormous medical bill as part of its effort to reduce the country's crippling debt.

International pharmaceutical companies are owed billions in unpaid bills. Novo Nordisk claims it is owed $36m (£24.9m) dollars by the Greek state.

The father of a 10-year-old Greek girl with diabetes called Nephele has written to Novo Nordisk's chairman saying there was more to health care than the bottom line.

"You could not have acted in a more insensitive manner at a more inopportune time," he wrote.

The Greek diabetes association was more robust, describing the Danes' actions as "brutal blackmail" and "a violation of corporate social responsibility".

The Danish chairman, Lars Sorensen, wrote to Nephele's father stressing that it was "the irresponsible management of finances by the Greek government which puts both you and our company in this difficult position".

People with diabetes in Greece have warned that some could die as a result of this action.

But a spokesman for Novo Nordisk said this issue was not about killing people. He pledged that the company would make traditional insulin products available free of charge to compensate.

Related Article:

Second firm withdraws drugs from Greece over cuts


Read more